Regeneron Pharmaceuticals, Inc. (BMV:REGN)

Regeneron Pharmaceuticals Statistics

Total Valuation

BMV:REGN has a market cap or net worth of MXN 1.09 trillion. The enterprise value is 810.86 billion.

Market Cap	1.09T
Enterprise Value	810.86B

Important Dates

The next estimated earnings date is Tuesday, October 28, 2025.

Earnings Date	Oct 28, 2025
Ex-Dividend Date	Aug 18, 2025

Share Statistics

Current Share Class	101.87M
Shares Outstanding	n/a
Shares Change (YoY)	-1.75%
Shares Change (QoQ)	-2.34%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	97.89M

Valuation Ratios

The trailing PE ratio is 12.91 and the forward PE ratio is 13.68.

PE Ratio	12.91
Forward PE	13.68
PS Ratio	4.05
PB Ratio	1.92
P/TBV Ratio	2.01
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 9.71, with an EV/FCF ratio of 11.16.

EV / Earnings	9.64
EV / Sales	3.08
EV / EBITDA	9.71
EV / EBIT	11.05
EV / FCF	11.16

Financial Position

The company has a current ratio of 4.60, with a Debt / Equity ratio of 0.09.

Current Ratio	4.60
Quick Ratio	3.57
Debt / Equity	0.09
Debt / EBITDA	0.60
Debt / FCF	0.70
Interest Coverage	108.11

Financial Efficiency

Return on equity (ROE) is 15.34% and return on invested capital (ROIC) is 7.78%.

Return on Equity (ROE)	15.34%
Return on Assets (ROA)	6.66%
Return on Invested Capital (ROIC)	7.78%
Return on Capital Employed (ROCE)	11.45%
Revenue Per Employee	17.66M
Profits Per Employee	5.54M
Employee Count	15,106
Asset Turnover	0.38
Inventory Turnover	2.46

Taxes

In the past 12 months, BMV:REGN has paid 7.85 billion in taxes.

Income Tax	7.85B
Effective Tax Rate	8.54%

Stock Price Statistics

The stock price has decreased by -46.89% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-46.89%
50-Day Moving Average	10,660.33
200-Day Moving Average	15,061.12
Relative Strength Index (RSI)	45.13
Average Volume (20 Days)	506

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	2.65

Income Statement

In the last 12 months, BMV:REGN had revenue of MXN 268.05 billion and earned 84.08 billion in profits. Earnings per share was 748.18.

Revenue	268.05B
Gross Profit	126.93B
Operating Income	74.62B
Pretax Income	91.93B
Net Income	84.08B
EBITDA	84.24B
EBIT	74.62B
Earnings Per Share (EPS)	748.18

Balance Sheet

The company has 140.86 billion in cash and 51.01 billion in debt, giving a net cash position of 279.53 billion.

Cash & Cash Equivalents	140.86B
Total Debt	51.01B
Net Cash	279.53B
Net Cash Per Share	n/a
Equity (Book Value)	564.59B
Book Value Per Share	5,422.68
Working Capital	248.79B

Cash Flow

In the last 12 months, operating cash flow was 89.45 billion and capital expenditures -16.78 billion, giving a free cash flow of 72.67 billion.

Operating Cash Flow	89.45B
Capital Expenditures	-16.78B
Free Cash Flow	72.67B
FCF Per Share	n/a

Margins

Gross margin is 47.35%, with operating and profit margins of 27.84% and 31.37%.

Gross Margin	47.35%
Operating Margin	27.84%
Pretax Margin	34.30%
Profit Margin	31.37%
EBITDA Margin	31.42%
EBIT Margin	27.84%
FCF Margin	27.11%

Dividends & Yields

This stock pays an annual dividend of 51.49, which amounts to a dividend yield of 0.49%.

Dividend Per Share	51.49
Dividend Yield	0.49%
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	4.18%
Buyback Yield	1.75%
Shareholder Yield	2.24%
Earnings Yield	7.74%
FCF Yield	6.69%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

BMV:REGN has an Altman Z-Score of 8.61 and a Piotroski F-Score of 4.

Altman Z-Score	8.61
Piotroski F-Score	4